Articles

Looking for an easy way to boost your portfolio’s yield by 30% and watch your dividends rise more than once a year? I’ve got one for you. And it’ll help you pick up some valuable international exposure, to boot.

All you have to do is look north, to Canada, where there are plenty of top-flight dividend stocks on sale now, like the two I’ll name a little further on.

I know that when most US investors think of Canada, they think of oil and gas—not exactly the best place to be right now. (And these days, some of us may be looking to our northern neighbor as a refuge if Donald Trump wins the presidency.)… Read more

Income investors, specifically those invested in stable Real Estate Investment Trusts (REITs), have been able to ignore most of the recent market mayhem. These issues have little exposure to energy prices, and China. Typically, they’re a pure U.S. economic play with stable income streams.

Plus, they’re pretty cheap right now. The Vanguard REIT Index Fund (VNQ) is paying its highest yield this decade (4.1%).

I’ve been a strong advocate of REITs since they became “too cheap” in mid-2015. After all, they’re legally required to pass along at least 90% of their earnings to shareholders. It’s a solid formula for market-beating dividend yields.… Read more

First, it was Kinder Morgan (KMI). Then, ConocoPhillips (COP). Which sacred dividend is going to get cut next?

Regular readers know that I believe big oil is a big avoid for now. But if you insist on speculating in the goo patch, stick with Exxon (XOM).

There are payout problems outside of energy, too. A quick look at Reality Shares’ DIVCON screen reveals seven 4% payers in “DIVCON 1” territory. This means they’re more likely to cut their dividend than raise it. Let’s discuss these, and a few more high yielding problem children.

1 Shaky Telecom

Frontier Communications Corp.… Read more

With all the bloviating on the campaign trail about reeling in drug costs these days, it’s safe to say the pharmaceutical industry is under siege.

But it’s not all the politicians’ fault; many of the sector’s injuries are self-inflicted. Case in point: Valeant Pharmaceuticals (VRX), whose stock has plunged 62% amid ongoing accounting concerns.

Investors, predictably, have voted with their feet: since the start of the year, the iShares US Pharmaceuticals ETF (IHE) has plunged almost 14%, nearly tripling the S&P 500’s decline.

But as with any selloff, it’s not just sickly stocks that are being punished. It’s the healthy ones, too.… Read more

Stocks that raise their dividend meaningfully every year will make you a lot of money over the long haul… provided they continue to boost their payouts, of course.

Studies by two global investment heavyweights, BlackRock and GMO, have shown that 90% of U.S. equity returns over the past 100 years have been thanks to dividends and dividend growth.

Ned Davis Research also conducted its own 43-year study on stock returns (from January 1972 through December 2014). The conclusion? Dividend payers are good… but dividend growers are great. Stocks that paid a growing dividend delivered double-digit returns and outpaced steady dividend payers by nearly one-third:

Annual Rate of Return (Ned Davis Research)

Over time, this compounding really adds up as these stocks pull away from stagnant payers and the market at-large:

Dividend Growers Pull Away Over Time

Worried about the Fed’s rate cycle?… Read more

Crude oil’s crash may have roiled stocks to start 2016, but cheap fuel is actually a great thing for the average American. Consumer confidence is heading higher, thanks to low gas prices and a continually improving job market. More disposable income means more fun for most Americans…

The recent Mintel American Lifestyles 2015 report shows that Americans are planning on increasing vacation travel by 27 percent. It’s a good time to buy stocks that are directly benefiting from this trend.

One of the largest online travel companies, Tripadvisor Inc (TRIP), just reported a solid quarter with increased consumer activity. And TRIP also detailed how their average monthly hotel shoppers grew by 10% year-over-year (to 113 million) in the last quarter of 2015.… Read more

If you’re a retiree, or a near-retiree, you’ve probably been told you should dump—or at least reduce—your stock holdings and focus on fixed-income investments.

It sounds like a smart move, right? After all, CDs, Treasuries and the like protect your principal, while one big downturn can wipe out your stock-market gains.

But going lean on stocks leaves you open to two big risks: that you’ll outlive your savings and miss out on the long-term gains only the stock market can offer.

Consider these numbers from the Society of Actuaries: if you’re a 65-year-old man, you have a 41% chance of living to 85 and 20% odds of hitting 90.… Read more

It’s a one-two punch I love to see in a stock: a growing dividend and a rock-solid commitment to research and development.

These companies serve up a profitable combo: immediate cash in your pocket and potential for huge gains—and even bigger dividend payouts—as they churn out the next wave of must-have products.

I bring this up because right now, S&P 500 companies are spending big on both R&D and dividends.

Here are the latest numbers from FactSet: in the 12 months ended September 30, 2015, S&P 500 firms poured $257.8 billion into R&D, a 10-year high. At the same time, they doled out $410.8 billion in dividend payments, also the highest total in at least a decade.… Read more